98%
921
2 minutes
20
Kidney involvement with resulting kidney failure leads to increased mortality in patients with multiple myeloma (MM). Cast nephropathy (CN), in particular, if left untreated, quickly leads to kidney failure requiring dialysis and has a very poor prognosis for the affected patient. The gold standard for diagnosing kidney involvement is a kidney biopsy. However, due to bleeding risk, this cannot be done in every patient. We recently reported that a quotient of urine light chain (LCurine) to glomerular filtration rate (eGFR) is a non-invasive diagnostic tool for patients with kidney involvement in MM. But this quotient has not yet been tested in everyday clinical practice. In this study, our LCurine/eGFR ratio was tested on 67 patients in two centers. Enrollment took place between January 2019 and September 2023. A total of 18 of the 67 patients had CN. With the threshold defined in our initial paper, we were able to show a sensitivity of 100% with a specificity of 85.7% for CN in patients with MM. As a result, the LCurine/eGFR quotient recognizes 100% of all CN and can therefore detect this group, which has a very poor prognosis, without the need for a kidney biopsy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11117468 | PMC |
http://dx.doi.org/10.3390/biomedicines12051032 | DOI Listing |
Clin Exp Nephrol
September 2025
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Background: Sacubitril/valsartan is typically prescribed for patients with heart failure and hypertension. We previously reported that sacubitril/valsartan provides comparable blood pressure (BP) reduction and superior tolerability compared to thiazide diuretics. This post hoc study aimed to compare the effects of sacubitril/valsartan and thiazide diuretics in patients with chronic kidney disease (CKD).
View Article and Find Full Text PDFBMJ Support Palliat Care
September 2025
Division of Nephrology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Background: End-stage kidney disease (ESKD) significantly impacts global public health, driven by an ageing population and increased chronic diseases. Over half of patients with ESKD are now over 65 years old, often with multiple comorbidities, complicating management and prognosis. The socioeconomic impact is considerable, and patients with ESKD face higher cancer risks.
View Article and Find Full Text PDFSemin Vasc Surg
September 2025
Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115; Center for Surgery and Public Health, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:
The rate of end-stage kidney disease (ESKD) is steadily rising in the United States, and older adults (ie, 65 years and older) represent the fastest-growing segment in need of hemodialysis. This demographic shift presents unique challenges due to age-related comorbidities, frailty, and increased procedural risks. Despite these challenges, there is limited guidance for risk stratification and management of renal replacement therapy in older patients with ESKD.
View Article and Find Full Text PDFAnn Vasc Surg
September 2025
Hospital das Clínicas, School of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil.
Background: To investigate whether endovascular repair of ruptured abdominal aortic aneurysm (RAAA), performed whenever anatomically feasible, would be superior in a real-world registry.
Methods: Retrospective analysis of consecutive RAAA patients treated at the emergency department of a single hospital from January 2011 to December 2023, after implementation of protocol-based care. The variables of interest were hemodynamic stability, proximal neck length, and type of intervention.
Clin J Am Soc Nephrol
September 2025
Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Background: Risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. The study aim was to assess competing risks of kidney failure and death in a real-world cohort with diabetes.
Methods: Cumulative incidence functions for kidney failure and death, stratified by baseline estimated glomerular filtration rate (eGFR), were estimated for the diabetes population from electronic health record data at Providence and the University of California Los Angeles health systems.